RBRC02829, B6.B6C3-Tg(Th-SNCA*130m)1702Yosh

RBRC No. RBRC02829
Type Transgene CongenicCartagena
Species Mus musculus
Strain name B6.B6C3-Tg(Th-SNCA*130m)1702Yosh
Former Common name Syn130m-1702, B6.Cg-Tg(Th-SNCA*)1702Yosh
H-2 Haplotype No Data
Background strain C57BL/6JJcl
1 Appearance No Data
Genotype No Data
Strain development Developed by Masaki Wakamatsu, Makoto Yoshimoto, Taisho Pharmaceutical Co., Ltd. in 2001. The transgene was injected into the pronuclei of B6C3F1 fertilized eggs. The mutant mice were backcrossed C57BL/6.
Strain description Th-SCNA transgenic mice expressing human alpha synuclein under the control of tyrosine hydroxylase promoter. Syn130m line (RBRC02829) having a human alpha synuclein sequence with an Ala53Thr point mutation and a lacking of 10 amino acids at the C-terminus, Syn140m line (RBRC02830) having a human alpa synuclein sequence with an Ala 53Thr point mutation. Syn130m line (RBRC02829) is useful as a model of Parkinson Disease. Syn130m Tg mice exhibit decreased dopamine level and dopaminergic neuron number. Motor activity and exploratory behavior are reduced compared to controls. Tg homozygous mice are postnatal lethal. Syn140m line (RBRC02830) is available as a control of Syn130m line. Syn140m Tg mice show no obvious abnormality.
Colony maintenance Carrier x Noncarrier [C57BL/6JJcl]
Health Report
Gene Details
Promoter No Data
1 Symbol HBB2
Symbol name rabbit beta-globin intron
Chromosome UN
Common name No Data
Symbol description No Data
2 Symbol polyA
Symbol name SV40 polyA-additional signal
Chromosome UN
Common name No Data
Symbol description No Data
Promoter rat tyrosine hydroxylase (TH) promoter
3 Symbol SNCA
Symbol name synuclein, alpha (human)
Chromosome UN
Common name synuclein, alpha
Symbol description No Data

Research applications Mouse Models for Human Disease
Specific Term and Conditions The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
Neurobiol. Aging, 29, 574-585 (2008).
Additional information
1 No Data
2 Genotyping protocol <PCR>
Depositor Taisho Pharmaceutical Co.,Ltd., (Taisho Pharmaceutical Co., Ltd.) Taisho Pharmaceutical Co.,Ltd.,
Strain Status /
(Expected delivery)

Cryopreserved embryos : Within 1 month
Recovered litters from cryopreserved embryos : 2-4 months

Cryopreserved sperm : Within 1 month
Recovered litters from cryopreserved sperm : 2-4 months